ADMA
ADMA Biologics Inc
9.70$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.8% | 23.8% | -2.7% | 42.6% | 20.9% | 42.7% | -17.1% | 17.3% | 9.9% | 25.6% | 50.9% | 23.7% | 26.7% | |
| 4.2% | 2.9% | 2.6% | 2.1% | 1.6% | 1.7% | 1.7% | 1.7% | 1.5% | 1.5% | 1.6% | 1.4% | 1.5% | |
| 2.5% | 2.4% | 2.6% | 2.7% | 2.7% | 4.6% | 4.0% | 4.1% | 3.8% | 3.9% | 5.5% | 4.9% | 4.5% | |
| 5.8% | 4.9% | -29.9% | 9.6% | -13.5% | 11.7% | -49.4% | -18.9% | -27.8% | -16.2% | 8.1% | -10.1% | -12.3% | |
| 1.1% | 1.6% | 2.9% | 1.9% | 0.9% | 2.3% | 4.1% | 2.0% | 10.7% | 0.8% | 2.2% | 1.8% | 4.0% | |
| -1.1% | -1.9% | -2.9% | -2.2% | -0.9% | -2.3% | -4.1% | -2.1% | -10.7% | -0.2% | 2.1% | -1.8% | -2.8% | |
| -0.3% | -0.5% | -3.0% | -0.6% | 2.6% | -0.5% | -6.3% | 0.0% | -17.2% | -6.4% | -113.7% | -20.1% | -36.5% | |
| – | – | – | – | -25.0% | -25.5% | 0.0% | 0.0% | -0.3% | -0.3% | 108.8% | -0.4% | 24.0% | |
| 0.6% | -52.8% | -1.8% | -0.3% | -21.3% | -26.4% | -6.2% | 0.0% | -20.7% | -6.6% | -8.8% | -23.6% | -14.9% | |
| 17.3% | -30.9% | -7.4% | 40.0% | -1.3% | 14.0% | -27.5% | 15.3% | -21.5% | 18.9% | 44.1% | -1.7% | 8.9% | |
| 16.7% | 22.2% | -5.6% | 40.7% | 20.0% | 40.4% | -21.2% | 15.3% | -0.8% | 24.8% | 48.7% | 21.9% | 22.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.